KEGG   PATHWAY: oro04115
Entry
oro04115                    Pathway                                
Name
p53 signaling pathway - Odobenus rosmarus divergens (Pacific walrus)
Description
p53 activation is induced by a number of stress signals, including DNA damage, oxidative stress and activated oncogenes. The p53 protein is employed as a transcriptional activator of p53-regulated genes. This results in three major outputs; cell cycle arrest, cellular senescence or apoptosis. Other p53-regulated gene functions communicate with adjacent cells, repair the damaged DNA or set up positive and negative feedback loops that enhance or attenuate the functions of the p53 protein and integrate these stress responses with other signal transduction pathways.
Class
Cellular Processes; Cell growth and death
Pathway map
oro04115  p53 signaling pathway
oro04115

Organism
Odobenus rosmarus divergens (Pacific walrus) [GN:oro]
Gene
101378264  ATM; serine-protein kinase ATM [KO:K04728] [EC:2.7.11.1]
101386368  CHEK2; serine/threonine-protein kinase Chk2 isoform X1 [KO:K06641] [EC:2.7.11.1]
101370393  ATR; serine/threonine-protein kinase ATR [KO:K06640] [EC:2.7.11.1]
101362614  CHEK1; serine/threonine-protein kinase Chk1 isoform X1 [KO:K02216] [EC:2.7.11.1]
101364626  GORAB; RAB6-interacting golgin [KO:K19748]
101385402  MDM2; E3 ubiquitin-protein ligase Mdm2 isoform X1 [KO:K06643] [EC:2.3.2.27]
101382575  MDM4; protein Mdm4 isoform X1 [KO:K10127]
101362427  TP53; cellular tumor antigen p53 [KO:K04451]
101380008  PPP1R13L; relA-associated inhibitor [KO:K27356]
101375107  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
101371532  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
101363193  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
101372891  CCND3; G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
101362330  CDK4; cyclin-dependent kinase 4 isoform X1 [KO:K02089] [EC:2.7.11.22]
101378405  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
101366323  CCNE2; G1/S-specific cyclin-E2 [KO:K06626]
101382136  CCNE1; G1/S-specific cyclin-E1 [KO:K06626]
101383299  CDK2; cyclin-dependent kinase 2 isoform X2 [KO:K02206] [EC:2.7.11.22]
101372536  SFN; 14-3-3 protein sigma [KO:K06644]
101382203  RPRM; protein reprimo [KO:K10128]
101375762  CCNB1; G2/mitotic-specific cyclin-B1 [KO:K05868]
101362162  CCNB2; G2/mitotic-specific cyclin-B2 [KO:K21770]
101366345  LOW QUALITY PROTEIN: G2/mitotic-specific cyclin-B2-like [KO:K21770]
101368443  CDK1; cyclin-dependent kinase 1 isoform X1 [KO:K02087] [EC:2.7.11.22 2.7.11.23]
101374376  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha isoform X1 [KO:K04402]
101374334  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
101363875  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
101385171  GTSE1; G2 and S phase-expressed protein 1 [KO:K10129]
101380323  ZNF385A; zinc finger protein 385A isoform X1 [KO:K26543]
101369551  FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
101365003  PIDD1; p53-induced death domain-containing protein 1 [KO:K10130]
101365855  CASP8; caspase-8 isoform X1 [KO:K04398] [EC:3.4.22.61]
101371120  BID; BH3-interacting domain death agonist [KO:K04726]
101371652  BAX; apoptosis regulator BAX isoform X1 [KO:K02159]
101362130  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]
101366869  BBC3; bcl-2-binding component 3 [KO:K10132]
101382878  SIVA1; apoptosis regulatory protein Siva [KO:K22744]
101380440  BCL2L1; bcl-2-like protein 1 isoform X1 [KO:K04570]
101372267  BCL2; apoptosis regulator Bcl-2 [KO:K02161]
101371351  TP53I3; quinone oxidoreductase PIG3 [KO:K10133] [EC:1.-.-.-]
101363618  EI24; etoposide-induced protein 2.4 homolog isoform X1 [KO:K10134]
101378736  SHISA5; protein shisa-5 [KO:K10135]
101378591  PERP; p53 apoptosis effector related to PMP-22 [KO:K10136]
101370979  ZMAT3; zinc finger matrin-type protein 3 isoform X1 [KO:K10137]
101383287  LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase SIAH1-like [KO:K04506] [EC:2.3.2.27]
101385058  SIAH1; E3 ubiquitin-protein ligase SIAH1 isoform X1 [KO:K04506] [EC:2.3.2.27]
101371511  E3 ubiquitin-protein ligase SIAH1-like [KO:K04506] [EC:2.3.2.27]
101386882  LOW QUALITY PROTEIN: cytochrome c, testis-specific-like [KO:K08738]
101386944  cytochrome c [KO:K08738]
101383104  APAF1; apoptotic protease-activating factor 1 isoform X1 [KO:K02084]
101362812  CASP9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
101371336  CASP3; caspase-3 isoform X2 [KO:K02187] [EC:3.4.22.56]
101371836  AIFM2; apoptosis-inducing factor 2 [KO:K22745]
101376941  IGFBP3; insulin-like growth factor-binding protein 3 isoform X1 [KO:K10138]
101386334  IGF1; insulin-like growth factor I isoform X1 [KO:K05459]
101382421  SERPINE1; plasminogen activator inhibitor 1 [KO:K03982]
101373163  ADGRB1; brain-specific angiogenesis inhibitor 1 [KO:K04596]
101365703  CD82; CD82 antigen isoform X1 [KO:K06509]
101376329  THBS1; thrombospondin-1 isoform X1 [KO:K16857]
101373624  SERPINB5; serpin B5 isoform X2 [KO:K10139]
101378738  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
101376333  RRM2; ribonucleoside-diphosphate reductase subunit M2 isoform X1 [KO:K10808] [EC:1.17.4.1]
101386612  LOW QUALITY PROTEIN: ribonucleoside-diphosphate reductase subunit M2-like [KO:K10808] [EC:1.17.4.1]
101386058  ribonucleoside-diphosphate reductase subunit M2-like isoform X1 [KO:K10808] [EC:1.17.4.1]
101382329  RRM2B; ribonucleoside-diphosphate reductase subunit M2 B isoform X1 [KO:K10808] [EC:1.17.4.1]
101378314  SESN3; sestrin-3 isoform X2 [KO:K10141]
101377519  SESN1; sestrin-1 isoform X1 [KO:K10141]
101386253  SESN2; sestrin-2 [KO:K20394]
101367385  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
101371494  TSC2; tuberin isoform X1 [KO:K07207]
101382919  STEAP3; metalloreductase STEAP3 [KO:K10142] [EC:1.16.1.-]
101375553  RFWD2; E3 ubiquitin-protein ligase RFWD2 isoform X1 [KO:K10143] [EC:2.3.2.27]
101382341  RCHY1; RING finger and CHY zinc finger domain-containing protein 1 isoform X1 [KO:K10144] [EC:2.3.2.27]
101365243  CCNG1; cyclin-G1 [KO:K10145]
101375094  CCNG2; cyclin-G2 [KO:K10146]
101369295  PPM1D; protein phosphatase 1D [KO:K10147] [EC:3.1.3.16]
101377328  TP73; tumor protein p73 isoform X2 [KO:K10148]
Reference
  Authors
Levine AJ, Hu W, Feng Z.
  Title
The P53 pathway: what questions remain to be explored?
  Journal
Cell Death Differ 13:1027-36 (2006)
DOI:10.1038/sj.cdd.4401910
Reference
  Authors
Harris SL, Levine AJ.
  Title
The p53 pathway: positive and negative feedback loops.
  Journal
Oncogene 24:2899-908 (2005)
DOI:10.1038/sj.onc.1208615
Reference
  Authors
Balint E E, Vousden KH.
  Title
Activation and activities of the p53 tumour suppressor protein.
  Journal
Br J Cancer 85:1813-23 (2001)
DOI:10.1054/bjoc.2001.2128
Reference
  Authors
Taylor WR, Stark GR.
  Title
Regulation of the G2/M transition by p53.
  Journal
Oncogene 20:1803-15 (2001)
DOI:10.1038/sj.onc.1204252
Reference
  Authors
Hofseth LJ, Hussain SP, Harris CC.
  Title
p53: 25 years after its discovery.
  Journal
Trends Pharmacol Sci 25:177-81 (2004)
DOI:10.1016/j.tips.2004.02.009
Reference
  Authors
Pietenpol JA, Stewart ZA.
  Title
Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis.
  Journal
Toxicology 181-182:475-81 (2002)
DOI:10.1016/S0300-483X(02)00460-2
Reference
  Authors
Tokino T, Nakamura Y.
  Title
The role of p53-target genes in human cancer.
  Journal
Crit Rev Oncol Hematol 33:1-6 (2000)
DOI:10.1016/S1040-8428(99)00051-7
Reference
  Authors
Hermeking H, Benzinger A.
  Title
14-3-3 proteins in cell cycle regulation.
  Journal
Semin Cancer Biol 16:183-92 (2006)
DOI:10.1016/j.semcancer.2006.03.002
Reference
  Authors
Sherr CJ.
  Title
Divorcing ARF and p53: an unsettled case.
  Journal
Nat Rev Cancer 6:663-73 (2006)
DOI:10.1038/nrc1954
Reference
  Authors
Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, Levine AJ.
  Title
The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.
  Journal
Cancer Res 67:3043-53 (2007)
DOI:10.1158/0008-5472.CAN-06-4149
Reference
  Authors
Resnick-Silverman L, Manfredi JJ
  Title
Two Faces of SIVA.
  Journal
Cancer Discov 5:581-3 (2015)
DOI:10.1158/2159-8290.CD-15-0484
Reference
  Authors
Resch U, Schichl YM, Winsauer G, Gudi R, Prasad K, de Martin R
  Title
Siva1 is a XIAP-interacting protein that balances NFkappaB and JNK signalling to promote apoptosis.
  Journal
J Cell Sci 122:2651-61 (2009)
DOI:10.1242/jcs.049940
Reference
  Authors
Barkinge JL, Gudi R, Sarah H, Chu F, Borthakur A, Prabhakar BS, Prasad KV
  Title
The p53-induced Siva-1 plays a significant role in cisplatin-mediated apoptosis.
  Journal
J Carcinog 8:2 (2009)
DOI:10.4103/1477-3163.45389
Reference
  Authors
Ohiro Y, Garkavtsev I, Kobayashi S, Sreekumar KR, Nantz R, Higashikubo BT, Duffy SL, Higashikubo R, Usheva A, Gius D, Kley N, Horikoshi N
  Title
A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF).
  Journal
FEBS Lett 524:163-71 (2002)
DOI:10.1016/S0014-5793(02)03049-1
Reference
  Authors
Hu Y, Ge W, Wang X, Sutendra G, Zhao K, Dedeic Z, Slee EA, Baer C, Lu X
  Title
Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-kappaB.
  Journal
Oncotarget 6:42478-90 (2015)
DOI:10.18632/oncotarget.6478
Related
pathway
oro04110  Cell cycle
oro04210  Apoptosis
oro04218  Cellular senescence
KO pathway
ko04115   
LinkDB

DBGET integrated database retrieval system